FREDERICK, Md. (AP) — The biopharmaceutical company MedImmune is opening a second manufacturing plant in Frederick.
Frederick city and county officials joined the company in celebrating the official opening Friday.
The new plant will expand production capacity for products including Synagis, a drug that prevents a respiratory virus
infection in high-risk children.
Gaithersburg-based MedImmune says it employs about 250 people in Frederick and expects to add more.
The company is a subsidiary of London-based AstraZeneca PLC.
(Copyright 2011 by The Associated Press. All Rights Reserved.)